WHSI
Wearable Health Solutions, Inc.
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
0.00
■ 0.00 (0.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
—
Prev close
0.00
Day high
0.00
Day low
0.00
Volume
300.00K
Market cap
—
P/E (TTM)
—
52W range
0.00 – 0.00
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
0.00%
-3.7%
3M
0.00%
-3.1%
6M
0.00%
-11.1%
YTD
0.00%
-12.3%
1Y
0.00%
-20.0%
3Y
-91.30%
-165.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2023 | 2022 | YoY |
|---|---|---|---|
| Total revenue | $745.09K | $1.05M | -28.8% |
| Operating revenue | $745.09K | $1.05M | -28.8% |
| Cost of revenue | $477.43K | $568.41K | -16.0% |
| Gross profit | $267.66K | $477.48K | -43.9% |
| Research & development | $49.68K | $390.83K | -87.3% |
| Selling, general & admin | $2.50M | $13.12M | -81.0% |
| Total operating expense | $2.56M | $13.52M | -81.1% |
| Operating income | -$2.29M | -$13.04M | +82.4% |
| Net interest income | -$113.82K | -$80.28K | -41.8% |
| Pre-tax income | -$2.39M | -$13.05M | +81.7% |
| Tax provision | $0 | $0 | — |
| Net income | -$2.39M | -$13.05M | +81.7% |
| Net income to common | -$2.39M | -$13.05M | +81.7% |
| Basic EPS | -0.00 | -0.01 | +87.0% |
| Diluted EPS | -0.00 | -0.01 | +87.0% |
| EBIT | -$2.27M | -$12.97M | +82.5% |
| EBITDA | -$2.26M | -$12.96M | +82.6% |
| Basic shares | 1.54B | 1.09B | +41.4% |
| Diluted shares | 1.54B | 1.09B | +41.4% |
| Line item | 2023 | 2022 | YoY |
|---|---|---|---|
| Cash & equivalents | $136.15K | $70.50K | +93.1% |
| Cash & short-term investments | $136.15K | $70.50K | +93.1% |
| Accounts receivable | $379 | $0 | — |
| Inventory | $8.55K | $7.06K | +21.1% |
| Total current assets | $152.33K | $297.41K | -48.8% |
| Property, plant & equipment | $70.85K | $41.65K | +70.1% |
| Total assets | $223.17K | $339.06K | -34.2% |
| Total current liabilities | $3.78M | $2.43M | +55.5% |
| Current debt | $2.73M | $1.92M | +42.6% |
| Total debt | $2.77M | $1.92M | +44.3% |
| Total liabilities | $3.80M | $2.43M | +56.3% |
| Retained earnings | -$41.81M | -$39.42M | -6.1% |
| Shareholder equity | -$3.58M | -$2.09M | -71.0% |
| Working capital | -$3.63M | -$2.13M | -70.1% |
| Net tangible assets | -$3.58M | -$2.09M | -71.0% |
| Shares issued | 1.57B | 1.49B | +4.9% |
| Line item | 2023 | 2022 | YoY |
|---|---|---|---|
| Net income | -$2.39M | -$13.05M | +81.7% |
| Depreciation & amortisation | $12.40K | $8.35K | +48.6% |
| Stock-based compensation | $294.36K | $10.04M | -97.1% |
| Change in working capital | $746.15K | -$71.19K | +1,148.2% |
| Operating cash flow | -$1.28M | -$3.11M | +58.8% |
| Capital expenditure | -$9.44K | -$50.00K | +81.1% |
| Investing cash flow | -$9.44K | -$50.00K | +81.1% |
| Financing cash flow | $1.35M | $2.38M | -43.1% |
| Free cash flow | -$1.29M | -$3.16M | +59.2% |
| End cash position | $136.15K | $70.50K | +93.1% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.00
+0.00% from price
SMA 20
0.00
0.00% from price
SMA 50
0.00
0.00% from price
SMA 100
0.00
+0.00% from price
SMA 200
0.00
0.00% from price
EMA 12
0.00
+0.00% from price
EMA 26
0.00
+0.00% from price
EMA 50
0.00
+0.00% from price
RSI (14)
31.8
Neutral
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.00
—
Realised vol 30D
0.0%
Annualised
Bollinger upper
0.00
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.00 vs 0.00
Trend bias
Below 200
0.00%
Risk profile
Beta vs SPY
0.00
Less volatile than market
Correlation to SPY
—
—
Realised vol 30D
0.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
0.0%
Peak to trough
Max drawdown 5Y
-99.7%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
—
5Y monthly, from filing
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.